QSA's Week in BioPharma (#1, 2025)
Canada, Saskatchewan boost rare disease drug access; MPs call for healthcare transformation; flu vaccination campaign kicks off.
Start Date: 2025-01-04
End Date: 2025-01-10
Top Headlines
Main Stories
Canada-Saskatchewan Agreement to Enhance Access to Rare Disease Drugs
The Government of Canada has announced a bilateral agreement with Saskatchewan aimed at improving access to drugs for rare diseases. The deal involves a $40 million investment to facilitate access to new and existing medications for conditions such as mycosis fungoides, hyperoxaluria type 1, and diffuse large B-cell lymphoma. This partnership aligns with the National Strategy for Drugs for Rare Diseases and marks a significant step towards improving early diagnosis and screening capabilities. The initiative could impact biopharmaceutical companies by potentially increasing demand for innovative treatments and fostering cooperation in drug price negotiations.
Sources: ['Announcements: www.canada.ca']
